BP003082: Recombinant Human CD319 / CRACC / SLAMF7 Protein
Source: mammalian cells.
Purity: > 95% by Bis-Tris PAGE and HPLC.BP003077: Recombinant Human SIRP alpha V8 Protein
Source: mammalian cells.
Purity: > 95% by Bis-Tris PAGE and HPLC.BP003079: Recombinant Human IL-10 Protein (rhIL-10-His)
Source: mammalian cells.
Purity: > 95% by Bis-Tris PAGE and HPLC.BP003078: Recombinant Human NKG2C&CD94 Heterodimer Protein
Source: mammalian cells.
Purity: > 95% by Bis-Tris PAGE and HPLC.BP4110: Recombinant Human PD1-His Fusion Protein
Source: HEK 293 cell-derived.
Purity: >95% by SDS-PAGE under reducing conditions.
Activity: The recombinant human PD1-His fusion protein binds recombinant human PDL1 at sub-micromolar range.
Endotoxin Level: Less than 1 EU/ug of protein as determined by LAL method.BP4109: Recombinant PD1-Fc fusion protein
Source: HEK 293 cell-derived.
Purity: >95% by SDS-PAGE under reducing conditions.
Activity: Recombinant PD1-Fc protein binds recombinant PDL1 protein at sub-micromolar range.
Endotoxin Level: Less than 1 EU/ug of protein as determined by LAL method.BP4107: Recombinant PDL1-Fc fusion protein
Source: HEK 293 cell-derived.
Purity: >95% by SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU/ug of protein as determined by LAL method.BP4108: Recombinant PDL1-FLAG fusion protein
Source: HEK 293 cell-derived.
Purity: >95% by SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU/ug of protein as determined by LAL method.BP000027-GD1: Recombinant Human VEGF165 (aa 27-191) Protein
Source: HEK 293 cell-derived.
The VEGF activity is measured in a cell proliferation assay using human umbilical vein endothelial cells (HUVEC). The ED50 for this effect is typically 1-5 ng/ml.
Endotoxin: < 1.0 EU per ug of the protein by the LAL method.
Purity: > 95% by SDS-PAGE under reducing conditions.BP000029-GD3: Recombinant Human FGF Acidic 136 (aa 19-155) Protein
Source: E. coli-derived.
The FGF acidic (aFGF/FGF-1/FGF1) activity is measured in a NIH/3T3 cell proliferation assay. The ED50 for this effect is typically 0.1-0.3 ng/ml in the presence of 10 ug/ml of heparin.
Endotoxin: <1.0 EU per 1 ug of the protein by the LAL method.
Purity: > 95% by SDS-PAGE under reducing conditions and visualized by silver stain.